Neville Rodie & Shaw Inc Matinas Bio Pharma Holdings, Inc. Transaction History

Neville Rodie & Shaw Inc

  • $1.36 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 06, 2023
SELL
$0.35 - $0.72 $208,658 - $429,240
-596,168 Reduced 34.0%
1,157,332 $417,000
Q2 2022

Jul 06, 2022
BUY
$0.63 - $0.96 $1.09 Million - $1.67 Million
1,736,000 Added 9920.0%
1,753,500 $1.39 Million
Q2 2018

Jul 03, 2018
BUY
$0.42 - $0.74 $7,350 - $12,950
17,500 New
17,500 $8,000

Others Institutions Holding MTNB

# of Institutions
6
Shares Held
3.52M
Call Options Held
0
Put Options Held
0
View Full List

About Matinas BioPharma Holdings, Inc.

MTNB Quotes by TradingView
  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $115M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Neville Rodie & Shaw Inc Portfolio

Follow Neville Rodie & Shaw Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neville Rodie & Shaw Inc, based on Form 13F filings with the SEC.

News

Stay updated on Neville Rodie & Shaw Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email